Certain mind tumors develop medication resistance by exploiting normal cellular signaling pathways Proteins that control cell development are mutated in malignancy, and their aberrant signaling drives the wild proliferation of cells that provides rise to tumors. Yet medicines devised to block its signaling tend to work only for some time, before cancer cells adjust to evade the therapy pharmacy article . Up to now, much of the study examining such drug level of resistance has focused on how mutations of other proteins in cancers cells allow them to resist medicines. But not all drug-resistant tumors harbor those additional mutations, suggesting they have evolved choice resistance mechanisms.
Certain Hodgkin lymphoma treatments put patients at increased risk for stomach cancer Hodgkin lymphoma survivors who received specific chemotherapy and radiation regimens were at increased threat of subsequently developing abdomen cancer, according to a study by scientists at the National Tumor Institute , portion of the National Institutes of Health. The study appeared Aug. 26, 2013, in the Journal of Clinical Oncology. Hodgkin lymphoma is a cancer of the disease fighting capability. It is one of the most common cancers among adolescents and adults in the usa.